Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 12, 2015, Pages 1542-1547

  Piggott, Damani A ^a,b   Varadhan, Ravi ^a   Mehta, Shruti H ^b   Brown, Todd T ^a,b   Li, Huifen ^a   Walston, Jeremy D ^a   Leng, Sean X ^a   Kirk, Gregory D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Frailty; HIV; Inflammation; Injection drug use; Mortality

Indexed keywords

IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; AGING; BLOOD; COMPLICATION; FEMALE; FRAIL ELDERLY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; SUBSTANCE ABUSE;

ADULT; AGED; AGING; FEMALE; FRAIL ELDERLY; HIV INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84959357498     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv107     Document Type: Article

References (46)

1. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Offce of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defc Syndr. 2012;60(suppl 1):S1-S18. doi:10.1097/QAI.0b013e31825a3668
2. Mills EJ, Bärnighausen T, Negin J. HIV and aging-preparing for the challenges ahead. N Engl J Med. 2012;366:1270-1273. doi:10.1056/NEJMp1113643
3. Brothers TD, Rockwood K. Biologic aging, frailty, and age-related disease in chronic HIV infection. Curr Opin HIV AIDS. 2014;9:412-418. doi:10.1097/COH.0000000000000070
4. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120-1126. doi:10.1093/cid/cir627
5. Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis. 2011;53:1256-1264. doi:10.1093/cid/cir673
6. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8:e81355. doi:10.1371/journal.pone.0081355
7. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:M255-M263. doi:10.1093/gerona/59.3.M255
8. Xue QL. The frailty syndrome: defnition and natural history. Clin Geriatr Med. 2011;27:1-15. doi:10.1016/j.cger.2010.08.009
9. Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61:262-266.
10. Fried L P, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M157. doi:10.1093/gerona/56.3.M146
11. Althoff KN, Jacobson LP, Cranston RD, et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Geron-tol A Biol Sci Med Sci. 2014;69:189-198. doi:10.1093/gerona/glt148
12. Desquilbet L, Jacobson LP, Fried L P, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62:1279-1286.
13. Erlandson KM, Allshouse AA, Jankowski CM, et al. Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials. 2012;13:324-334. doi:10.1310/hct1306-324
14. McAdams-DeMarco MA, Law A, Salter ML, et al. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc. 2013;61:896-901. doi:10.1111/jgs.12266
15. Onen NF, Agbebi A, Shacham E, Stamm KE, Onen AR, Overton ET. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect. 2009;59:346-352. doi:10.1016/j.jinf.2009.08.008
16. Pathai S, Gilbert C, Weiss HA, et al. Frailty in HIV-infected adults in South Africa. J Acquir Immune Defc Syndr. 2013;62:43-51. doi:10.1097/QAI.0b013e318273b631
17. Piggott DA, Muzaale AD, Mehta SH, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One. 2013;8:e54910. doi:10.1371/journal.pone.0054910
18. Singh T, Newman AB. Infammatory markers in population studies of aging. Ageing Res Rev. 2011;10:319-329. doi:10.1016/j.arr.2010.11.002
19. Fabbri E, An Y, Zoli M, et al. Aging and the burden of multimorbidity: associations with infammatory and anabolic hormonal biomarkers. J Gerontol A Biol Sci Med Sci. 2015;70:63-70. doi:10.1093/gerona/glu127
20. Franceschi C, Campisi J. Chronic infammation (infammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S4-S9. doi:10.1093/gerona/glu057
21. Newman AB, Sachs MC, Arnold AM, et al. Total and cause-specifc mortality in the cardiovascular health study. J Gerontol A Biol Sci Med Sci. 2009;64:1251-1261. doi:10.1093/gerona/glp127
22. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med. 2003;115:429-435.
23. Deeks SG. HIV infection, infammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141-155. doi:10.1146/annurev-med-042909-093756
24. Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of functional impairment with infammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis. 2013;208:249-259. doi:10.1093/infdis/jit147
25. Hearps AC, Martin GE, Rajasuriar R, Crowe SM. Infammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing. Curr HIV/AIDS Rep. 2014;11:20-34. doi:10.1007/s11904-013-0190-8
26. Kuller LH, Tracy R, Belloso W, et al. Infammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203. doi:10.1371/journal.pmed.0050203
27. Sandler NG, Sereti I. Can early therapy reduce infammation? Curr Opin HIV AIDS. 2014;9:72-79. doi:10.1097/COH.0000000000000020
28. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci. 2014;69:833-842. doi:10.1093/gerona/glt168
29. Collerton J, Martin-Ruiz C, Davies K, et al. Frailty and the role of infam-mation, immunosenescence and cellular ageing in the very old: cross-sectional fndings from the Newcastle 85+ Study. Mech Ageing Dev. 2012;133:456-466. doi:10.1016/j.mad.2012.05.005
30. Hubbard RE, O'Mahony MS, Savva GM, Calver BL, Woodhouse KW. Infammation and frailty measures in older people. J Cell Mol Med. 2009;13:3103-3109. doi:10.1111/j.1582-4934.2009.00733.x
31. Leng SX, Xue QL, Tian J, Walston JD, Fried LP. Infammation and frailty in older women. J Am Geriatr Soc. 2007;55:864-871. doi:10.1111/j.1532-5415.2007.01186.x
32. Walston J, McBurnie MA, Newman A, et al.; Cardiovascular Health Study. Frailty and activation of the infammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162:2333-2341. doi:10.1001/archinte.162.20.2333
33. Varadhan R, Yao W, Matteini A, et al. Simple biologically informed infam-matory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J Gerontol A Biol Sci Med Sci. 2014;69:165-173. doi:10.1093/gerona/glt023
34. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75-100.
35. Salter ML, Lau B, Mehta SH, Go VF, Leng S, Kirk GD. Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections. J Acquir Immune Defc Syndr. 2013;64:488-495. doi:10.1097/QAI.0b013e3182a7ee2e
36. Fedarko NS. The biology of aging and frailty. Clin Geriatr Med. 2011;27:27-37. doi:10.1016/j.cger.2010.08.006
37. Le T, Wright EJ, Smith DM, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013;368:218-230. doi:10.1056/NEJMoa1110187
38. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793-800. doi:10.1093/cid/ciq243
39. Kavasery R, Galai N, Astemborski J, et al. Nonstructured treatment interruptions among injection drug users in Baltimore, MD. J Acquir Immune Defc Syndr. 2009;50:360-366. doi:10.1097/QAI.0b013e318198a800
40. Westergaard RP, Hess T, Astemborski J, Mehta SH, Kirk GD. Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS. 2013;27:2559-2566. doi:10.1097/QAD.0b013e328363bff2
41. Kirk GD, Merlo CA; Lung HIV Study. HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc. 2011;8:326-332. doi:10.1513/pats.201009-061WR
42. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991-1001. doi:10.1111/j.1532-5415.2006.00745.x
43. Roubenoff R. The "cytokine for gerontologists" has some company. J Ger-ontol A Biol Sci Med Sci. 2014;69:163-164. doi:10.1093/gerona/glt184
44. Sanders JL, Ding V, Arnold AM, et al. Do changes in circulating biomark-ers track with each other and with functional changes in older adults? J Gerontol A Biol Sci Med Sci. 2014;69:174-181. doi:10.1093/gerona/glt088
45. Schöttker B, Saum KU, Jansen EH, et al. Oxidative stress markers and all-cause mortality at older age: a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2015;70:518-524. doi:10.1093/gerona/glu111
46. Simard EP, Fransua M, Naishadham D, Jemal A. The infuence of sex, race/ethnicity, and educational attainment on human immunodefciency virus death rates among adults, 1993-2007. Arch Intern Med. 2012;172:1591-1598. doi:10.1001/archinternmed.2012.4508